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ABSTRACT
Objective: To present the development and validation of  an instrument for characterizing people, aged 50 or over, who are carriers of  the 
Human Immunodeficiency Virus / Acquired Immunodeficiency Syndrome. Methods: The content of  the instrument, which was developed 
based on consulted literature and the professional experience of  the researchers, was validated by seven experts. The validation was performed 
in two stages of  evaluation, using the Kendall coefficient of  concordance to evaluate, the first time, concordance among experts with regard 
to relevance, clarity, and completeness of  content, and secondly, the adequacy and comprehensiveness. The Cochran test was used to evaluate 
the concordance regarding clarity, in the second evaluation. Results: There was disagreement among the experts in the first evaluation, and 
after reformulation of  the instrument, concordance was obtained in the second evaluation. Conclusion: The instrument for characterizing this 
population was validated against the content being used by researchers, and is now made available for use. 
Keywords: HIV; Acquired immunodeficiency syndrome; Adult; Validation studies.
RESUMO
Objetivo: Apresentar o desenvolvimento e a validação de um instrumento para caracterização de pessoas, com 50 anos ou mais, portadoras do 
Vírus da Imunodeficiência Humana/Síndrome da Imunodeficiência Adquirida. Métodos: O conteúdo do instrumento, elaborado com base 
na literatura consultada e experiência profissional dos pesquisadores, foi validado por sete peritos. A validação foi feita em dois momentos 
de avaliação, utilizando-se o coeficiente de concordância de Kendall para avaliar no primeiro momento a concordância entre os juízes quanto 
à pertinência, clareza e abrangência do conteúdo e, no segundo, a pertinência e abrangência. O teste de Cochran foi utilizado para avaliar a 
concordância quanto à clareza, na segunda avaliação. Resultados: Observou-se discordância entre os peritos na primeira avaliação e após a 
reformulação do instrumento, obteve-se concordância na segunda avaliação. Conclusão: O instrumento para caracterização dessa população 
foi validado em relação ao conteúdo, sendo aplicado pelos pesquisadores e encontra-se disponível para utilização. 
Descritores: HIV; Síndrome de imunodeficiência adquirida; Adulto; Estudos de validação.
RESÚMEN
Objetivo: Presentar el desarrollo y la validación de un instrumento para la caracterización de personas, con 50 años o más, portadoras del Virus de 
la Inmunodeficiencia Humana/Síndrome de la Inmunodeficiencia Adquirida. Métodos: El contenido del instrumento, elaborado con base en la 
literatura consultada y experiencia profesional de los investigadores, fue validado por siete peritos. La validación fue realizada en dos momentos de 
evaluación, utilizándose el coeficiente de concordancia de Kendall para evaluar en el primer momento la concordancia entre los jueces en cuanto a 
la pertinencia, claridad y alcance del contenido y, en segundo, la pertinencia y alcance. El test de Cochran fue utilizado para evaluar la concordancia 
en relación a la claridad, en la segunda evaluación. Resultados: Se observó discordancia entre los peritos en la primera evaluación y después de 
la reformulación del instrumento, se obtuvo concordancia en la segunda evaluación. Conclusión: El instrumento para la caracterización de esa 
población fue validado en relación al contenido, siendo aplicado por los investigadores encontrándose disponible para su utilización. 
Descriptores: VIH; Síndrome de inmunodeficiencia adquirida; Adulto; Estudios de validación. 
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Validação do conteúdo de instrumento para caracterizar pessoas maiores de 50 anos portadoras do Vírus da 
Imunodeficiência Humana/Síndrome da Imunodeficiência Adquirida
Validación del contenido de un instrumento para caracterizar a personas mayores de 50 años portadoras del 
Virus de la Inmunodeficiencia Humana/Síndrome de la Inmunodeficiencia Adquirida
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INTRODUCTION
The epidemic caused by the human immunodefi-
ciency virus (HIV) represents a dynamic and unstable 
global phenomenon, the form of  occurrence depending 
on other determinants, such as individual and collective 
human behavior, in different regions of  the world. The 
Acquired Immunodeficiency Syndrome (Aids) stands out 
among the emerging infectious diseases, because of  the 
great magnitude and extent of  damage to populations (1).
The increase in the number of  Aids cases among older 
adults has been reported worldwide (2). In Brazil, between 
1996 and 2006, the incidence rate per 100 thousand in-
habitants aged 50-59 years, increased from 17.9 to 29.3 
among men, and from 6.0 to 17.3 among women. In the 
same period, there was an increase in the incidence rate 
among individuals over 60 years. Among men, the rate per 
100 thousand inhabitants increased from 5.9 to 8.8 and in 
women, from 1.7 to 5.1 (3). In this context it is important 
to recognize that Aids in the elderly is characterized as 
a social phenomenon of  large proportions, impacting 
moral, religious and ethical principles, procedures for 
public health and private behavior, questions related to 
sexuality, drug use and conjugal morality that require 
critical professionals, open to new values , trained in the 
complexity of  the virus and disease caused by it, and with 
knowledge of  health policies (4).  
Thus, to properly direct their work with this group 
of  patients, nurses should be directed to recognize the 
characteristics of  this “new generation” of  older people 
with HIV / Aids. This information should subsidize 
educational activities that can contribute to improving 
the care provided to elderly people with HIV / Aids 
and, above all, take a preventive form with this popula-
tion, to avoid contagion. To design these interventions, 
however, it is essential to accurately characterize this 
group of  subjects. Given the paucity of  related studies, 
we found the need to develop an instrument that would 
allow such exploration.
In developing an instrument for data collection, 
the researcher should be aware that the phenomena of  
interest must be translated into concepts that can be 
measured, observed or recorded. The task of  selecting 
or developing methods for collecting data is among 
the most challenging in the research process. Without 
adequate methods for data collection, the validity of  the 
research conclusions is easily questioned (5). Thus, some 
important points should be considered throughout the 
process of  developing an instrument for data collection: 
extensive review of  literature and all forms of  tests and 
measurements that address the theme, the experience 
of  the researcher in the area to be studied, the care and 
monitoring of  the formulation of  each question regard-
ing clarity, consistency, relevance and impartiality, and, 
the evaluation of  the instrument by experts in the field 
of  knowledge and testing to verify that the instrument 
was formulated with clarity, without bias, and that it is 
useful for the generation of  the desired information (5 - 7). 
The validation of  an instrument can be understood as a 
methodological procedure by which the quality is evalu-
ated, and which can be defined as the capacity of  an 
instrument to accurately measure that which it is intended 
to measure, i.e., the phenomenon of  concern. There are 
three main types of  validity, namely: content, construct 
and criterion-related (5 – 8). 
This study aimed to develop an instrument, and to 
analyize its content validity, for the characterization of  
people aged 50 or over, living with HIV/Aids, consider-
ing their sociodemographic and clinical characteristics, 
their health behaviors, and their beliefs and attitudes 
towards ongoing treatment.
METHODS
Development of  the instrument
The instrument was designed after an extensive litera-
ture review (9 -13), also considering the clinical experience 
of  the researchers. The first version was composed of  
58 questions divided into four major sections, described 
below:
Sociodemographic characteristics: gender; marital 
status; religion; age; children; education; profession; how 
respondent occupied his time; number of  people residing 
with the respondent; responsibility for the upkeep of  the 
home; income; and, support in times of  difficulty.
Clinical characteristics: viral load; T CD4+ cell 
count; disease classification; opportunistic diseases treated; 
current opportunistic diseases; use of  antiretroviral medi-
cations; presence of  other nonopportunistic diseases.
Health behaviors: habits (smoking, alcoholism or 
drug addiction); sexual relationships; monogomy / stable 
partner; current and past use of  protection during sexual 
relations; reason for use / non-use of  protection; sexual 
relationship with more than one person before diagnosis 
of  HIV / Aids; and, use of  medication to aid sexual 
performance.
Beliefs and attitudes about the disease and treat-
ment: time and form of  knowledge about contamination 
/ disease; beliefs as to how the disease was acquired; 
present and past complications related to HIV / Aids 
reported by the patient; treatment time; treatment adher-
ence; and, reasons for abandonment of  the treatment.
Pilot test
The first version of  the instrument was administered 
to four people more than 50 years of  age who were 
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seropositive for HIV / Aids, and afterward the tool was 
redesigned in accordance with identified needs, with the 
collaboration of  a nursing professor who had experience 
in developing tools for data collection.
Content Validation
The redesigned instrument was initially submitted for 
evaluation by seven experts who were recognized for their 
expertise in the area of  study, or who had experience in 
validation of  measurement instruments for the evaluation 
of  conceptual adequacy, relevance, comprehensiveness, 
and clarity of  the items. The panel of  experts consisted 
of: a doctorally prepared nurse with experience in care 
and teaching in the area of  infectious/contagious disease; 
a doctorally prepared nurse with experience in valida-
tion of  instruments; a doctorally prepared nurse with 
experience in care and teaching in the area of  infectious/
contagious disease; a master’s-prepared nurse, with ex-
perience in management of  health services in the area 
of  infectious/contagious disease, with an emphasis on 
management of  a Day Hospital unit for HIV/Aids; a 
doctorally-prepared physician with experience in teach-
ing and research in the area of  infectious/contagious 
disease, in particular, with patients seropositive for HIV/
Aids; a doctorally-prepared physician, with experience in 
teaching and research in the clinical area of  medical/ge-
riatrics/ gerontology; and, a doctorally-prepared linguist 
and university professor. The inclusion of  a linguist was 
to verify the objective and development of  adequacy of  
the components that made up the questions.
The experts were sent a letter, specifying the evalu-
ation criteria and the request for review, along with a 
copy of  the proposed instrument for data collection, 
and an evaluation form for each item. The material was 
presented personally to six experts, and mailed to one 
of  them. Evaluations were returned to the researchers 
after, approximately, 25 days. The items were evaluated 
for clarity and relevance, not only to evaluate the com-
prehensiveness of  the questionnaire as a whole.
After analyzing the data, the instrument was rede-
signed in accordance with the guidelines and suggestions 
from the experts, and was then returned to four out of  
the seven experts who worked in the area of   infectious 
diseases and geriatrics/gerontology for a second evalu-
ation. Revaluations were returned after approximately 
30 days.
Data Analysis
The agreement among the experts for the evaluation 
criteria of  relevance and clarity of  the questionnaire was 
verified using the Kendall (W) coefficient of  concordance 
which ranges from 0 to 1. High W-values (W ≥ 0.66) (14) 
can be interpreted as indicating that the experts applied 
the same standards of  evaluation. Low W-values  suggest 
disagreement among the experts.
To incorporate the suggestions of  the experts on the 
evaluated items of  the instrument, after the first evalu-
ation, we considered the percentage of  agreement ob-
tained in each item. Items with less than 80% agreement 
for any one of  these evaluated criteria (relevance, clarity), 
were deleted or changed. We established for acceptance 
criteria of  the items, those with discriminating power - 
Favorable or Unfavorable – with agreement among the 
experts of  equal to or greater than 80%, conforming to 
what was encountered within the literature (10, 12, 15). After 
re-structuring the instrument and the second evaluation 
by experts, we tested the agreement between the experts 
for the criteria of  relevance and comprehensiveness of  
the items, using the Kendall (W) coefficient of  concor-
dance and the Cochran Q-test, which has the property 
of  verifying if  the opinion of  the experts differed signifi-
cantly, to analyze the criterion of  clarity. The significance 
level adopted was 5%.
Ethical aspects
The research project was approved by the Committee 
on Ethics in Research of  the Faculty of  Medical Sciences, 
UNICAMP, in Opinion No. 275/2007 and the experts 
participating in the study signed a Term of  Free and 
Informed Consent.
RESULTS
The first version of  the instrument consisted of  four 
main sections, namely: sociodemographic characteristics, 
clinical characteristics, health behaviors, and, beliefs and 
attitudes about the disease and the treatment they were 
receiving. Each section had subitems, adding up to a total 
of  58 questions.
In the section on sociodemographic and clinical character-
istics, regarding the first evaluation of  the instrument 
by the experts, the value of  the Kendall coefficient was 
0.231 (p-value = 0.026) for relevance and 0.114 (p-value 
= 0.751) for clarity. In the health behaviors section, the value 
of  the Kendall coefficient was 0.143 (p-value = 0.457) 
for relevance and 0.102 (p-value = 0.806) for clarity. In 
the section on beliefs and attitudes about illness and treatment, 
the value of  the Kendall coefficient was 0.241 (p-value 
= 0.070) for relevance and 0.251 (p-value = 0.056) for 
clarity. These values  denote disagreement among the 
experts as to the clarity and relevance in the sections 
that comprised the first version of  the instrument. This 
fact highlighted the need to make modifications to the 
instrument, according to the suggestions and comments 
made by experts. To proceed with the corrections, we 
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considered the acceptance criteria for each item, with 
discriminative power - favorable or unfavorable – equal 
to or greater than 80% agreement among the experts.
Based on the evaluation and suggestions of  the 
experts, some items were excluded: city of  residence; 
address; living conditions; completion of  a course; con-
dition in which the individual was in relation to work; 
occupation; free time activities; personal income; receipt 
of  any financial assistance; smoking history; history of  
alcoholism; blank space for any final message by the re-
spondent. Other items that had less than 80% agreement 
in the expert evaluation were modified, according to the 
suggestions made, thus obtaining the second version of  
the instrument which consisted of  the same sections, 
with a total of  43 questions. In the second evaluation, 
using the redesigned instrument, we obtained absolute 
agreement among the experts for the relevant criteria 
in all sections of  the instrument (Kendall coefficient = 
1.00, p = 0.001).
With regard to the criterion of  clarity, we used the 
Cochran Q-test (Table 1), in which a score of  1 signified 
that the option is clear and a score of  -1 signified that 
the option was not clear; the  items in the data collection 
instrument were evaluated by the experts. There was a 
statistically significant agreement among the experts for 
clarity in the sections of  health behaviors, and beliefs and 
attitudes about illness and treatment (p = 0.392, Cochran 
Q-test). In the  sociodemographic characteristics and clinical 
characterstics sections, there were differences among the 
experts for the evaluation criteria of  clarity (p = 0.0001, 
Cochran Q-test). Thus, we needed an adaptation of  these 
sections of  this instrument with regard to the clarity of  
the questions. We incorporated the new suggestions of  
experts before drafting the final version to be distributed 
to the study population.
Both the first and second evaluation obtained agree-
ment among the experts in regard to the comprehen-
siveness of  the instrument (Table 2), with the Kendall 
coefficient of  1.00 (p = 0.001). The final instrument 
(Appendix 1) was distributed to a target population and 
formed the basis of  the master’s thesis prepared by the 
first author (16). 
DISCUSSION
Data from this study reinforced the importance 
of  using rigorous methods for the development of  
instruments validated by experts. Specifically in the 
context of  this study, it highlighted the importance of  
the developed instrument .
The increase in the number of  older people living 
with HIV/Aids has been reported in Brazil, as in other 
parts of  the world. In this study, we considered the age 
group of  50 years or older, because the majority of  stud-
ies involving people with HIV/Aids involve those up 
through 49 years of  age. The number of  people aged 50 
to 60 years who are infected by the disease is considerable, 
which presents peculiarities regarding the manifestation 
of  their needs, functional capabilities and cultural val-
ues (17-18). However, we observed a lack of  appropriate 
instruments that consider the particular and individual 
characteristics for these individuals. This fact was noted 
by the authors at the completion of  the primary literature 
review. We did not encounter any instrument that had 
been constructed specifically to study this segment of  
the population.
Several factors guided and supported the construction 
and validation of  the contents of  the instrument, such 
as: the increase in the number of  sexually active older 
people using unsafe sexual practices (19);  the use of  alco-
hol and drugs (20); lack of  knowledge about the risks for 
infection with HIV/Aids and the need for prevention (21); 
Table 1. Expert agreement regarding the criteria of  clarity of  the data collection instrument for patients aged 50 or older, living 
with HIV/Aids. Campinas, 2008.
Experts
Sociodemographic and clinical 
characteristics Health behaviors
Beliefs and attitudes about the 
disease and its treatment
Not clear Clear Not clear Clear Not clear Clear
Rjuiz1 2 17 0 13 1 10
Rjuiz2 0 19 0 13 0 11
Rjuiz3 0 19 1 12 0 11
Rjuiz4 9 10 1 12 0 11
Table 2. Expert agreement regarding the criteria of  comprehensiveness of  the data collection instrument for patients aged 50 or older, 
living with HIV/Aids Campinas, 2008.
Evaluated Items
Comprehensiveness - n (%)
Yes No Without Opinion
Sociodemographic and clinical characteristics 6 (86) 1 (14) 0 (0)
Health behaviors 6 (86) 1 (14) 0 (0)
Beliefs and attitudes about the disease and its treatment 6 (86) 1 (14) 0 (0)
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lack of  preparation of  health professionals to identify the 
elderly as sexually active, thereby losing an opportunity to 
provide necessary information for disease prevention (22); 
and, prejudice and stigma (on the part of  relatives and 
friends) towards this population, with regard to sexual-
ity and the presence of  sexually transmitted disease (19). 
This study presents strong points for obeying the 
elements considered to be key in developing a reliable 
and valid instrument that is based on evidence of  the 
problem to be assessed/measured (22): clear definition of  
the target population; accurate determination of  what 
should be measured and the purpose of  each measure; 
determination of  those items that could be measured 
using only one question, or requiring more than one, 
to meet the proposed objectives; determination of  an 
appropriate response format for the target population; 
evaluation of  the sequence of  questons presented, 
conforming to the intended goals; and involvement of  
experts in the  process of  evaluating the instrument. 
However, it is important to note that, at this point, only 
the content validity evaluation is presented. In future 
studies, it would be interesting to assess other properties 
of  the measurement instrument, for example, reliability 
using the criterion of  reproducibility, i.e., the verifica-
tion of  proportion of  agreement among  the responses, 
when the instrument is applied to the same individual 
by different professionals.
This is a novel instrument within the nation. Its ap-
plication will allow us to obtain important information 
to guide the priorities of  care for patients over 50 years 
of  age with HIV/Aids. The use of  the instrument in dif-
ferent cultural environments will allow the comparison 
and identification of  similar points that may become 
the target of  collective actions aimed at improving the 
quality of  health care and its outcomes with this group 
of  patients, which has been, in reality, underestimated.
CONCLUSION
The instrument developed for the characterization of  
people aged 50 or over living with HIV/Aids was vali-
dated with respect to content, after careful revision of  its 
items. After it was redesigned, the items were considered 
relevant and comprehensive by the experts (both with 
agreement by Kendall = 1.0; p = 0.001), which pernits 
it to be available for use in further studies.
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Appendix - Instrument. Characterization of  individuals aged 50 or over living with HIV / Aids
1. SOCIODEMOGRAPHIC AND CLINICAL CHARACTERISTICS 
1.1. IDENTIfICATION
1.1.1) Gender: ( 1 ) masculine     ( 2 ) feminine
1.1.2) What is your marital status? ( 1 ) married     ( 2 ) single     ( 3 ) separated / divorced       ( 4 ) widowed     ( 5 ) living together  
( 6 ) other. What? _________________________________________________________________ 
1.1.3) What is your religion? ( 1 ) Catholic     ( 2 ) Evangelical     ( 3 ) Protestant     ( 4 ) Jehovah’s Witness     
( 5 ) Do not have a religion  ( 6 ) other. What? ________________________________________________
1.1.4) How old are you? ______ years. (Date of  birth: ____ / ____ / ______)
1.1.5) Do you have children? ( 1 ) no  ( 2 ) yes.     1.1.5.1) How many? __________________ children
1.1.6) Have you attended school? ( 1 ) no     ( 2 ) yes.     
1.1.6.1) To what grade? _______ grade (____ years of  study completed)
1.1.7) What is your profession? ___________________________________________________________________________________
1.1.8) How do you spend most of  your time?____________________________________________________________________
1.2. INCOME
1.2.1) How many people live with you? (1) living alone (2) 1 to 3 people (3) 4 to 6 people (4) more than 6 people
1.2.2) Are you primarily responsible for the upkeep of  the house?  (1) no (2) yes
1.2.3) What is your household income, per month? R$ _____________ (___ minimum wages) (1) did not know (2) did not respond
1.2.4) In times of  trouble, does someone help you? (1) no (2) yes 
1.2.4.1) Who? (1) friends (2) partner (3) family (4) other ______________________________
1.3. CLINICAL DATA
The interviewer will get the data from the patient’s medical record:
1.3.1) Last result for the patient’s viral load: ____________________________________ Date: _______________
1.3.2) Last result for the patient’s T CD4+: ____________________________________ Date: _______________
1.3.3) Current rating of  the disease (HIV/Aids): _______________________________ Date: _______________
1.3.4) Has had any opportunistic disease related to HIV/Aids?: (1) No (2) Yes (3) not in the record (s). 
1.3.4.1) If  so, what? ____________________________________________________________________________
1.3.5) Currently has some opportunistic disease(s) related to HIV/Aids?: (1) No (2) Yes (3) not in the record (s). 
1.3.5.1) If  so, what? ____________________________________________________________________________
1.3.6) Uses antiretroviral drugs?: (1) No (2) Yes (3) not in the record (s). 
1.3.6.1) If  so, what? ____________________________________________________________________________
1.3.7) Currently presents with other nonopportunistic diseases?: (1) No (2) Yes (3) not in the record (s). 
1.3.7.1) If  so, what? ___________________________________________________________________________
1.3.8) Currently uses other drugs, not antiretrovirals?: (1) No (2) Yes (3) not in the record (s). 
1.3.8.1) If  so, what? _____________________________________________________________________________
2. HEALTH BEHAVIORS
2.1. HABITS
2.1.1) Do you smoke? ( 1 ) no     ( 2 ) yes
2.1.1.1) How long have you smoked? ______________________________________________
2.1.1.2) How many cigarettes do you smoke per day? __________________________________
2.1.2) Do you use alcohol? (1) no (2) yes
2.1.2.1) How long have you used it? _______________________________________________
2.1.2.2) How much do you drink per day? ___________________________________________
2.1.3) Do you use drugs? (1) no (2) yes
2.1.3.1) How long have you used them? _____________________________________________
2.1.3.2) What kind of  drugs do you use? ____________________________________________
2.1.3.3) How often do you use them per day? ________________________________________
2.1.3.4) Do you use needles and syringes? (1) no (2) yes
2.1.3.4.1) Do you share needles and syringes? (1) no (2) yes
2.1.3.4.2) Where do you get the syringes and needles for use? ___________________________________________
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2.2. SEXUALITY
2.2.1) Do you still have sexual relationships? (1) no (2) yes
The questions numbered 2.2.2 to 2.2.5.2.1 shall be asked of  respondents who are still having sexual relationships
2.2.2) Who is your sexual partner? 
(1) person(s) of  the same gender as you (2) person(s) of  different gender than you (3) person(s) of  both genders
2.2.3) Do you have a stable partner? (1) no (2) yes 
2.2.3.1) How long? ____________________ 
2.2.3.2) Do you live under the same roof? (1) no (2) yes
2.2.4) Do you have sexual relationships with more than one person today? (1) no (2) yes
2.2.5) Do you use any kind of  protection in sexual relations today? (1) no (2) yes 
2.2.5.1) What? ______________________________________________________________________________________________ 
2.2.5.2) Do you have any trouble using it? (1) no (2) yes 
2.2.5.2.1) What?______________________________________________________________________________________________
2.2.6) Before discovering you carried HIV/Aids, did you have sex with more than one person? (1) no (2) yes
2.2.7) Before discovering you carried HIV/Aids, did you use some kind of  protection during sexual relationships? (1) no (2) yes
2.2.7.1) What?_______________________________________________________________________________________________ 
2.2.7.2) Did you have trouble using it? (1) no (2) yes 
2.2.7.2.1) What?_____________________________________________________________________________________________
If  the respondent does/did not use/wear protection in his/her sexual relationships: 
2.2.8) Why do/did you not use protection in your sexual relationships? ______________________________________________
__________________________________________________________________________________________________________
2.2.9) Do you use some medication to help your sexual performance? (1) no (2) yes 
2.2.9.1) Which one (s)? ______________________________________________________________________ 
2.2.9.2) How long have you used it? ____________________________________________________________
If  the respondent uses medication to help sexual performance: 
2.2.10) Has the drug led to improvement in your sexual performance? (1) no (2) yes 
2.2.10.1) In relation to what? ___________________________________________________________________________________
3. BELIEfS AND ATTITUDES ABOUT THE DISEASE AND TREATMENT
3.1) How long ago did you learn that you have HIV/Aids? 
(A) less than 1 year   (2) 1-3 years   (3) 4-6 years   (4) 7-9 years   (5) over 9 years   (6) does not remember
3.2) How did you learn that you had HIV/Aids? 
(1) during the medical consultation / collection of  routine tests   (2) during a hospital stay   (3) during pregnancy
(4) upon request of  serology tests for having had relations with a person infected with HIV/Aids
(5) What other way?_______________________________________
3.3) How do you believe you acquired HIV/Aids? 
(1) sex   (2) blood transfusion   (3) using injection drugs    
(4) other.    What? __________________________     (5) does not know
3.4) Have you had any complications in your health related to HIV/Aids? (1) no (2) yes 
3.4.1) What?    (1) pneumonia   (2) eye infection   (3) diarrhea   (4) problem / infection in the head     (5) thrush
(6) lymphoma / cancer    (7) other.  What? __________________________________________________
3.5) Do you currently have any health complications related to HIV/Aids?   (1) no   (2) yes 
3.5.1) What?    (1) pneumonia   (2) eye infection   (3) diarrhea   (4) problem / infection in the head     (5) thrush
(6) lymphoma / cancer    (7) other.  What? __________________________________________________
3.6) How long ago did you start treatment for HIV/Aids? 
(A) less than 1 year   (2) 1-3 years   (3) 4-6 years   (4) 7-9 years   (5) over 9 years   (6) does not remember
3.7) With the treatment you are receiving for HIV/Aids, do you feel: 
(1) better (2) neither better nor worse (3) worse
3.8) Have you ever left treatment? (1) no (2) yes
3.8.1) Why?_________________________________________________________________________________________________
If  the respondent has ever abandoned treatment, ask the next three questions:
3.9) How many times have you left  treatment? _________________
3.9.1) For how long? __________________________________________________________________________________________
3.10) When you stopped treatment, was there a change in your disease? (1) no (2) yes 
3.10.1) What?______________________________________________________________________________________________
3.11) What made you return to the treatment? ___________________________________________________________________
_________________________________________________________________________________________________________
